These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 8706146

  • 1. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
    Satoh M, Okamoto Y, Koshio H, Ohta M, Nishida A, Akuzawa S, Miyata K, Mase T, Semple G.
    Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1412-4. PubMed ID: 8706146
    [Abstract] [Full Text] [Related]

  • 2. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K.
    J Med Chem; 1997 Jan 31; 40(3):331-41. PubMed ID: 9022799
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y.
    J Pharmacol Exp Ther; 1994 May 31; 269(2):725-31. PubMed ID: 7910212
    [Abstract] [Full Text] [Related]

  • 4. New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonists.
    Satoh M, Kondoh Y, Okamoto Y, Nishida A, Miyata K, Ohta M, Mase T, Murase K.
    Chem Pharm Bull (Tokyo); 1995 Dec 31; 43(12):2159-67. PubMed ID: 8582018
    [Abstract] [Full Text] [Related]

  • 5. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K.
    Aliment Pharmacol Ther; 1997 Feb 31; 11(1):113-20. PubMed ID: 9042983
    [Abstract] [Full Text] [Related]

  • 6. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
    Attoub S, Moizo L, Laigneau JP, Alchepo B, Lewin MJ, Bado A.
    Fundam Clin Pharmacol; 1998 Feb 31; 12(3):256-62. PubMed ID: 9646057
    [Abstract] [Full Text] [Related]

  • 7. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
    Yuki H, Nishida A, Miyake A, Ito H, Akuzawa S, Takinami Y, Takemoto Y, Miyata K.
    Dig Dis Sci; 1997 Apr 31; 42(4):707-14. PubMed ID: 9125636
    [Abstract] [Full Text] [Related]

  • 8. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, Miyata K.
    J Pharmacol Exp Ther; 1994 Sep 31; 270(3):1256-61. PubMed ID: 7932178
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
    Ding XQ, Håkanson R.
    Pharmacol Toxicol; 1996 Sep 31; 79(3):124-30. PubMed ID: 8884870
    [Abstract] [Full Text] [Related]

  • 10. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F, Revel L, Letari O, Mennuni L, Impicciatore M.
    Eur J Pharmacol; 1999 Mar 12; 369(1):81-90. PubMed ID: 10204685
    [Abstract] [Full Text] [Related]

  • 11. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
    Ding XQ, Håkanson R.
    Pharmacol Toxicol; 1996 Dec 12; 79(6):324-30. PubMed ID: 9000260
    [Abstract] [Full Text] [Related]

  • 12. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
    Kitano M, Norlén P, Ding XQ, Nakamura S, Håkanson R.
    Br J Pharmacol; 2000 Jun 12; 130(3):699-705. PubMed ID: 10821801
    [Abstract] [Full Text] [Related]

  • 13. Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats.
    Ding XQ, Kitano M, Håkanson R.
    Pharmacol Toxicol; 1998 Apr 12; 82(4):177-82. PubMed ID: 9584331
    [Abstract] [Full Text] [Related]

  • 14. Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Veber DF, Freidinger RM, Chang RS, Lotti VJ.
    J Med Chem; 1988 Jan 12; 31(1):176-81. PubMed ID: 3336017
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
    Ding XQ, Lindström E, Håkanson R.
    Pharmacol Toxicol; 1997 Jul 12; 81(1):19-25. PubMed ID: 9258980
    [Abstract] [Full Text] [Related]

  • 16. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
    Ding XQ, Lindström E, Håkanson R.
    Br J Pharmacol; 1997 Sep 12; 122(1):1-6. PubMed ID: 9298521
    [Abstract] [Full Text] [Related]

  • 17. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
    Saita Y, Yazawa H, Honma Y, Nishida A, Miyata K, Honda K.
    Eur J Pharmacol; 1994 Oct 14; 269(2):249-54. PubMed ID: 7851501
    [Abstract] [Full Text] [Related]

  • 18. Antagonistic effect of YM022, an antiulcer agent in rats, on human cholecystokinin (CCK)B/gastrin receptor.
    Koizumi T, Saita Y, Miyake A, Nishida A, Yazawa H, Honda K.
    Jpn J Pharmacol; 1996 Aug 14; 71(4):307-13. PubMed ID: 8886928
    [Abstract] [Full Text] [Related]

  • 19. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Håkanson R, Ding XQ, Norlén P, Lindström E.
    Regul Pept; 1999 Mar 17; 80(1-2):1-12. PubMed ID: 10235629
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of gastrin-induced gastric acid secretion by antisense oligonucleotide to the CCKB/gastrin receptor.
    Rao RK, Lopez Y, Lai J, Riviere PJ, Junien JL, Porreca F.
    Neuroreport; 1995 Nov 27; 6(17):2373-7. PubMed ID: 8747156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.